Jerry Mclaughlin
President and Chief Executive Officer
Drug Discovery and Drug Development
AgeneBio Inc
United States of America
Biography
Jerry McLaughlin is serving as President and Chief Executive Officer of AgeneBio since June 2014. He has 27 years of executive, operational and commercial leadership experience in the biopharmaceutical industry. Prior to joining AgeneBio, he served as the Senior Vice President and Chief Commercial Officer of NuPathe Inc. until the company was acquired by Teva Pharmaceuticals Industries Ltd. in 2014. Mr. McLaughlin served in a variety of commercial leadership roles at Merck from 1990 to 2001 and Endo Pharmaceuticals from 2001 to 2007. He holds a BA in Economics from Dickinson College and an MBA from Villanova University.
Research Interest
Bio-pharmaceuticals, Pharmaceuticals Industries, Commercial Leadership
